Manel Juan

Head of Immunology Hospital Clinic Barcelona

Dr. Manel Juan Otero is Head of Immunology at Hospital Clínic de Barcelona, where he leads work spanning clinical immunology, immunotherapy and anti-tumor cell immunotherapy. His expertise covers allergy, autoimmunity, immunodeficiencies, transplant immunology and immunotherapy, with a current focus on anti-tumor immunotherapy. He has led research and clinical initiatives in genetically engineered T-cell therapies, including the CART19 Immunotherapy project for cancer treatment. Dr. Juan Otero previously served as Head of Section in Immunology at Hospital Clínic Barcelona and has held leadership roles within the Catalan Society of Immunology. He holds an MD and PhD in Immunology from the Universitat de Barcelona.

Seminars

Wednesday 10th February 2027
Introducing Point of Care Manufacturing Opportunities to Expand Patient Access to Cell Therapies
1:45 pm
  • Identifying the critical success factors for establishing a decentralised manufacturing network, including technology transfer, quality oversight, site readiness and partner selection
  • Demonstrating how a point-of-care manufacturing model reduced treatment timelines and expanded patient access through a real-world implementation case study
  • Exploring the network of point of care manufacturing
Wednesday 10th February 2027
Roundtable Discussion: Evaluating the Role of Hospital Exemptions & Point of Care Manufacturing to Expand Access Beyond Conventional CAR-T
2:15 pm
  • Exploring how regulations and appetite for both POC and hospital exemptions differ across the region to understand implementation feasibility across Europe 
  • Evaluating the long-term commercial viability of POC manufacturing, examining whether reduced logistics and turnaround times can outweigh quality control, regulatory and scalability challenges
  • Defining what constitutes sufficient clinical evidence to support broader adoption, reimbursement and physician confidence in alternative CAR-T delivery models
Manel Juan